In this first-of-its-kind partnership for its Dental
Solutions business, Solventum, formerly 3M Health Care, is striving to focus on longevity
and durability of permanent same-day restorative dental offerings,
reaffirming its commitment to solving industry's toughest
problems
Partnership aims to integrate innovative new material
science and disruptive technology like chairside 3D printing to
optimize workflows, enhance procedural efficiency and benefit both
patients and practitioners
ST.
PAUL, Minn., March 25,
2025 /PRNewswire/ -- Solventum (NYSE: SOLV), the
leader in dental composites and restorative dentistry, today
announced a strategic partnership with SprintRay, a leading
provider of chairside 3D dental printing, to meet the needs of
dentists with in-office chairside 3D printed crowns, inlays, onlays
and more. This research and development (R&D) and
commercialization agreement is focused on developing and bringing
to market high-quality, durable and permanent same-day restorations
– with the quality patients and dentists expect from the current
multi-visit laboratory fabricated procedures.
Solventum Dental Solutions connects leading-edge materials with
data science to help dentists solve their toughest challenges with
products such as Filtek™ Easy Match Universal Restorative, Filtek™
Matrix, Scotchbond™ Universal and RelyX™ Universal Cement.
SprintRay offers innovative chairside end-to-end 3D printing
ecosystems, which create a platform for a wide range of restorative
dental applications.
With Solventum's legacy of best-in-class material science with
leading restorative materials, and SprintRay's innovative
technology, the partnership aims to bring to market the first
permanent chairside, 3D printed crown. Together, Solventum and
SprintRay anticipate improvement in patient experience and outcomes
through fewer office visits – driving practice efficiency, and
ultimately, delivering the outcomes patients and providers
demand.
"Imagine a world where your dentist can create a crown that can
last decades in a matter of minutes," said Karim Mansour, President, Dental Solutions,
Solventum. "We believe this partnership will revolutionize the way
dentists and orthodontists care for patients with in-office
production, offering a simplified procedure that we anticipate will
improve outcomes and experiences, reduce chair time and lower
treatment costs. This collaboration allows us to integrate the
latest technological advancements into our proven restorative
solutions, ensuring we remain at the forefront of dental innovation
to deliver unparalleled care to our patients."
Offering cutting-edge 3D printing technology directly to
dentists and orthodontists will streamline care for patients and
providers, allowing the delivery of same-visit dentistry and
introducing a market for permanent 3D printed crowns,
inlays, onlays and more.
"Together, we can make a significant impact in restorative
dentistry by building exceptional products for same-visit
treatment," said SprintRay CEO Amir
Mansouri. "Our partnership with Solventum is a key
collaboration and commitment to making a difference in people's
oral health as well as enabling high-quality and cost-effective
dental restorations across the globe."
The announcement of the partnership aligns with Solventum's
legacy of quality material science and is one example of biasing
resources towards growth while strengthening digital capabilities,
two elements of Solventum's previously announced three-phased plan.
As the winner of seven Dental Advisor awards in 2024, the
partnership follows four new product introductions launched in
2024, including:
- 3M™ Clarity™ Precision Grip Attachments, the first 3D printed
aligner attachments
- 3M™ Clinpro™ Clear Fluoride Treatment, a new water-based
formula for smoother application and a more comfortable patient
experience
- Clarity™ Flex + Force Aligners, new proprietary multi-layer
copolymer extruded in different thicknesses to best express varying
degrees of movement
- 3M™ Filtek™ Easy Match Universal Restorative features naturally
adaptive opacity and offers an intuitive shade selection process to
simplify direct restorative procedures
Solventum will share more details about the strategic
partnership at the International Dental Show (IDS) 2025 on
March 26 in Cologne, Germany.
About Solventum
At Solventum, we enable better, smarter, safer healthcare to
improve lives. As a new company with a long legacy of creating
breakthrough solutions for our customers' toughest challenges, we
pioneer game-changing innovations at the intersection of health,
material and data science that change patients' lives for the
better — while empowering healthcare professionals to perform at
their best. See how at Solventum.com.
Forward-Looking Statements
This news release contains forward-looking information about
Solventum's financial results, estimates, and business prospects
that involve substantial risks and uncertainties. In particular,
statements regarding the future performance of Solventum, including
guidance for 2024, are forward-looking statements. You can identify
these statements by the use of words such as "anticipates,"
"believes," "could," "estimates," "expects," "forecasts," "goal,"
"guidance," "intends," "may," "outlook," "plans," "projects,"
"seeks," "sees," "should," "targets," "will," "would," and other
words and terms of similar meaning in connection with any
discussion of future operating or financial performance or business
plans or prospects. Among the factors that could cause actual
results to differ materially are the following: (1) the effects of,
and changes in, worldwide economic, political, regulatory,
international, trade and geopolitical conditions, natural
disasters, war, public health crises, and other events beyond
Solventum's control; (2) operational execution risks; (3) damage to
our reputation or our brands; (4) risks from acquisitions,
strategic alliances, divestitures and other strategic events; (5) ;
the highly competitive environment in which Solventum operates and
consolidation in the healthcare industry; (6) reduction in
customers' research budgets or government funding; (7) the timing
and market acceptance of Solventum's new product and service
offerings; (8) ongoing working relationships with certain key
healthcare professionals; (9) changes in reimbursement practices of
governments or private payers or other cost containment measures;
(10) Solventum's ability to obtain components or raw materials
supplied by third parties and other manufacturing and related
supply chain difficulties, interruptions, and disruptive factors;
(11) risks related to the highly regulated environment in which
Solventum operates; (12) Solventum's failure to obtain, maintain,
protect, or effectively enforce its intellectual property ("IP")
rights.
Changes in such assumptions or factors could produce
significantly different results. A further description of these
factors is located under "Cautionary Note Regarding Forward-Looking
Statements" and "Risk Factors" in Solventum's periodic reports on
file with the U.S. Securities & Exchange Commission. Solventum
assumes no obligation to update any forward-looking statements
discussed herein as a result of new information or future events or
developments.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/solventum-partners-with-sprintray-to-disrupt-the-digital-dentistry-market-with-high-quality-permanent-same-day-restorations-302411305.html
SOURCE Solventum
